Protalix BioTherapeutics (PLX) Shares Outstanding (Diluted) (2011 - 2026)

Protalix BioTherapeutics (PLX) Shares Outstanding (Diluted) (2011 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Outstanding (Dil.) (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	255.20 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	106.00 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	64.41 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	398.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	115.80 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	138.28 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	241.70 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	217.35 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	556.90 Mn
10	Protalix BioTherapeutics	189.97 Mn	149.31 Mn	12.13 Mn	82.56 Mn

Download Data